Jean Rogers
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
Highest-materiality recent filing
CH4 Natural Solutions units may now separate into Class A shares and warrants
Holders can elect to separately trade Class A ordinary shares and warrants from units effective June 22, 2026.
CH4 Natural Solutions completes partial over-allotment, adds $20M to trust at $220M
Underwriter purchased 2M over-allotment units at $10/unit, adding $20M gross proceeds.
CH4 Natural Solutions completes $200M SPAC IPO; proceeds placed in trust
IPO of 20M units at $10/unit grossed $200M; $2M private placement also closed.
CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE
IPO of 20M units at $10/unit; each unit: 1 Class A share + 1/2 warrant.
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
On April 30, 2026, Nate Zwald, Lauren Singer, Jean Rogers, Jeffrey Tepper and Ben Veres were appointed as members of the Board of Directors of the Company (the “ Board ”).
Max materiality 0.60 · Median 0.47 · Most common event other_material